Measuring adherence to antiretroviral treatment: The role of pharmacy records of drug withdrawals

AIDS and Behavior

Volumn 16, Issue 6, 2012, Pages 1482-1490

  Gutierrez, Eliana Battaggia ^a,d   Sartori, Ana Marli Christovam ^a   Schmidt, Ana Lucia ^a   Piloto, Bruna Mamprim ^a   França, Bruna Biagi ^b   De Oliveira, Adriana Santos ^a   Pouza, Adriana Rodrigues ^a   Moreno, Roberta Vilela ^a   De Melo Picone, Camila ^a   De Almeida Ribeiro, Manoel Carlos Sampaio ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PONTIFÍCIA UNIVERSIDADE CATÓLICA DE SÃO PAULO   (Brazil)

^c FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^d Faculdade de Ciências Médicas da Santa Casa de São Paulo ^*  (Brazil)

Author keywords

Adherence; AIDS; Antiretroviral treatment; HIV; Pharmacy based measures; Self reporting

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; BRAZIL; CROSS-SECTIONAL STUDY; ELECTRONIC MEDICAL RECORD; EVALUATION; FEMALE; HOSPITAL PHARMACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE; SELF REPORT; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; VIROLOGY; VIRUS LOAD;

ADULT; AGED; AMBULATORY CARE FACILITIES; ANTI-RETROVIRAL AGENTS; BRAZIL; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACY SERVICE, HOSPITAL; QUESTIONNAIRES; RECORDS AS TOPIC; SELF REPORT; SOCIOECONOMIC FACTORS; VIRAL LOAD;

EID: 84865200519     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0168-3     Document Type: Article

References (22)

1. Ministério da Saúde/Secretaria de Vigilância em Saúde/Programa DST/AIDS. Brazilian policy to control the epidemic. 2002. Available at: http://www.aids.gov.br/sites/default/files/anexos/publicacao/2002/ 40454/portugu-s-ingl-s-19474.pdf. Accessed 22 Dec 2011.
2. GM Rocha CJ Machado FA Acurcio MDC Guimaraes 2011 Monitoring adherence to antiretroviral treatment in Brazil: an urgent challenge Cad Saude Publica 27 Suppl 1 S67 S78 21503526 10.1590/S0102-311X2011001300008
3. D Donnell JM Baeten J Kiarie, et al. 2010 Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis Lancet 375 2092 2098 20537376 10.1016/S0140-6736(10)60705-2
4. TC Porco JN Martin KA Page-Shafer, et al. 2004 Decline in HIV infectivity following the introduction of highly active antiretroviral therapy AIDS 18 81 88 15090833 10.1097/00002030-200401020-00010 (Pubitemid 38402321)
5. B Taiwo 2009 Adherence to antiretroviral therapy: the more you look, the more you see Curr Opin HIV AIDS 4 488 492 20048715 10.1097/COH.0b013e3283311058
6. R Grossberg Y Zhang R Gross 2004 A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV J Clin Epidemiol 57 1107 1110 15528063 10.1016/j.jclinepi.2004.04.002 (Pubitemid 39451804)
7. KM Berg JH Arnsten 2006 Practical and conceptual challenges in measuring antiretroviral adherence J Acquir Immune Defic Syndr 43 Suppl 1 S79 S87 17133207
8. PF Bonolo RRFM Gomes MDC Guimarães 2007 Adherence to antiretroviral treatment (HIV/AIDS): associated factors and adherence measures Epidemiologia e Serviços de Saúde 16 251 259
9. L Polejack EM Seidl 2010 Monitoring and evaluation of adherence to ARV treatment for HIV/AIDS: challenges and possibilities Cien Saude Colet 15 Suppl 1 1201 1208 20640279 10.1590/S1413-81232010000700029
10. TJ Podsadecki BC Vrijens EP Tousset RA Rode GJ Hanna 2008 "White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients HIV Clin Trials 9 238 246 18753118 10.1310/hct0904-238
11. JH McMahon MR Jordan K Kelley, et al. 2011 Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring Clin Infect Dis 52 493 506 21245156 10.1093/cid/ciq167
12. RRFM Gomes CJ Machado FA Acurcio MDC Guimaraes 2009 Pharmacy records as an indicator of non-adherence to antiretroviral therapy by HIV-infected patients Cad Saude Publica 25 495 506 19300838
13. F Bonolo Pde CJ Machado CC Cesar MG Ceccato MD Guimaraes 2008 Vulnerability and non-adherence to antiretroviral therapy among HIV patients, Minas Gerais State, Brazil Cad Saude Publica 24 2603 2613 19009140 10.1590/S0102-311X2008001100015
14. MI Nemes HB Carvalho MF Souza 2004 Antiretroviral therapy adherence in Brazil AIDS 18 Suppl 3 S15 S20 15322479 10.1097/00002030-200406003-00004 (Pubitemid 39037454)
15. RS Braithwaite MJ Kozal CC Chang, et al. 2007 Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies AIDS 21 1579 1589 17630553 10.1097/QAD.0b013e3281532b31 1:CAS:528:DC%2BD2sXns1Cmtro%3D (Pubitemid 47075479)
16. CR Blatt CB Citadin FG Souza RS Mello D Galato 2009 Assessment of adherence to antiretroviral drugs in a municipality in southern Brazil Rev Soc Bras Med Trop 42 131 136 19448928 10.1590/S0037-86822009000200007
17. DL Paterson S Swindells J Mohr, et al. 2000 Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 21 30 10877736 1:STN:280:DC%2BD3czit1altA%3D%3D (Pubitemid 30432540)
18. DR Bangsberg 2006 Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression Clin Infect Dis 43 939 941 16941380 10.1086/507526 1:CAS:528:DC%2BD28XhtVKhsrbP (Pubitemid 44435526)
19. J Shuter JA Sarlo TJ Kanmaz RA Rode BS Zingman 2007 HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95% J Acquir Immune Defic Syndr 45 4 8 17460469 10.1097/QAI.0b013e318050d8c2 1:CAS:528: DC%2BD2sXksFOltro%3D (Pubitemid 46684437)
20. AB Kobin NU Sheth 2011 Levels of adherence required for virologic suppression among newer antiretroviral medications Ann Pharmacother 45 372 379 21386024 10.1345/aph.1P587 1:CAS:528:DC%2BC3MXksVGktLw%3D
21. JJ Parienti K Ragland F Lucht, et al. 2010 Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication Clin Infect Dis 50 1192 1197 20210643 10.1086/651419
22. M Rosenblum SG Deeks M van der Laan DR Bangsberg 2009 The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy PLoS One 4 e7196 19787058 10.1371/journal.pone.0007196